Skip to Main Content

Isaac Kinde (M13)

  • B.S. Biological Sciences, UMBC (2005)
  • MD/Ph.D., The Johns Hopkins University (2015)

Chief Scientific Officer at PapGene, Inc.

Kinde is developing techniques to improve the accuracy of DNA sequencing technology

“I will apply this technology to detect asymptomatic colon cancers from DNA isolated from the stool of patients, hopefully leading to the end goal of decreasing mortality from colorectal cancer.”